SEC Form 4 · accession 0001179110-18-014194
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joanna Horobin
Officer — Chief Medical Officer
Period of report
Dec 20, 2018
Accepted (ET)
Dec 20, 2018 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2018 | P | 300 | $3.45 | A | 2,044 | D |
Table II — derivative securities
No Table II lines on this filing.